Shortage: Lidocaine Hydrochloride Injection — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) Status: Current Used for: Anesthesia

Shortage: Lorazepam Injection — Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) Status: Current Reason: Other Used for: Neurology

Shortage: Sufentanil Citrate Injection — Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) Status: Current Reason: Other Used for: Analgesia/Addiction, Pediatric

Shortage: Fentanyl Citrate Injection — Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) Status: Current Used for: Analgesia/Addiction, Pediatric

Shortage: Lidocaine Hydrochloride Injection — Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) Status: Current Used for: Anesthesia

Shortage: Dexamethasone Sodium Phosphate Injection — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) Status: Current Used for: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology…

Shortage: Promethazine Hydrochloride Injection — Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35) Status: Current Reason: Demand increase for the drug Used for: Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy

Shortage: Midazolam Hydrochloride Injection — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) Status: Current Used for: Anesthesia, Neurology

Shortage: Liraglutide Injection — Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) Status: Current Used for: Endocrinology/Metabolism

Shortage: Propranolol Hydrochloride Injection — Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) Status: Current Reason: Shortage of an active ingredient Used for: Cardiovascular

Shortage: Midazolam Hydrochloride Injection — Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) Status: Current Used for: Anesthesia, Neurology

Shortage: Remifentanil Hydrochloride Injection — Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10) Status: Current Reason: Demand increase for the drug Used for: Analgesia/Addiction

Shortage: Lisdexamfetamine Dimesylate Capsule — Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) Status: Current Reason: Shortage of an active ingredient Used for: Psychiatry

Convenience Kit RecallThe maker or a government agency pulled this product. Check the model or lot number and stop using it until it's fixed or refunded.: Medline Removes Convenience Kits Affected by BD ChloraPrep Applicator Recall Certain Medline convenience kits containing recalled BD ChloraPrep applicators should be removed from use due to potential fungal contamination

Shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01) Status: Current Reason: Shortage of an active ing…

Shortage: Quinapril Hydrochloride Tablet — Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) Status: Current Reason: Requirements related to complying with good manufacturing practices Used for: Cardiovascular

Shortage: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01) Status: Current Reason: Shortage of an active ingredient Used for…

Shortage: Quinapril Hydrochloride Tablet — Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) Status: Current Reason: Requirements related to complying with good manufacturing practices Used for: Cardiovascular

Shortage: Quinapril Hydrochloride Tablet — Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) Status: Current Reason: Requirements related to complying with good manufacturing practices Used for: Cardiovascular

Par Health Issues Voluntary Nationwide RecallThe maker or a government agency pulled this product. Check the model or lot number and stop using it until it's fixed or refunded. of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to t…

Shortage: Methylprednisolone Acetate Injection — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) Status: Current Reason: Shortage of an active ingredient Used for: Rheumatology

Shortage: Ketorolac Tromethamine Injection — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) Status: Current Used for: Analgesia/Addiction

Shortage: Clindamycin Phosphate Injection — Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06) Status: Current Reason: Discontinuation of the manufacture of the drug Used for: Anti-Infective

Shortage: Ketorolac Tromethamine Injection — Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) Status: Current Used for: Analgesia/Addiction

Benzoyl Peroxide Wash, USP, 10%, packaged in a)5 FL OZ (148mL) bottles (NDC 0536-1261-63), and b) 8.5 FL OZ (237 mL) bottles (NDC 0536-1351-42), Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152. Reason: Microbial contamination of topical product. Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · IL only

Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3. Reason: Defective Container; packets were found to be either empty or partially full. Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · Nationwide in the USA.

FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19 Reason: Lack of Assurance of Sterility Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · VA

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe17 reports about syringe on this site. See them all → packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36. Reason: Temperature Abuse: Product sat in a non-temperature-controlled FedEx trail…

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3 Reason: Failed dissolution specifications. Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · US Nationwide.

Benzoyl Peroxide Wash, USP, 5%, 5 FL OZ (148 mL), Distributed by: Rugby Laboratories, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152. NDC: 0536-1259-63 Reason: Microbial contamination of topical product. Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · IL only